The effectiveness of an anticoagulant in stroke has been proven

The FDA has approved the anticoagulant Brilinta for use in patients with cardiovascular disease.

The drug for amyotrophic lateral sclerosis has impressed neurologists

In a small study, a biotech company has tested its own amyotrophic lateral sclerosis drug.

Osteoporosis - From Idea to Action. Zoleum.

On 22nd of September 2020 the company "Ananta Medicare" in association with "Clinic of modern rheumatology" held the first webinar on the topic of osteoporosis. The lecture "Osteoporosis - from idea to action" was conducted by prof. Egudina Elizaveta Davydovna.

Swiss company is interested in finding new drug targets

Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.

New effective drug for Cushing's syndrome

The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.

The World Health Organization expects to receive at least 2 billion doses of COVID-19 vaccines next year

The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.

GALAPAGOS and GILEAD have demonstrated victory over scleroderma

Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.

VIR Biotechnology has demonstrated a new effective drug for hepatitis B prevention

Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.

Orphan drug status has been assigned to new glioblastoma drug

The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.

Tumor hypoxia - a new method for fighting cancer

A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.